Filing Details

Accession Number:
0001209191-14-038854
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-03 21:28:37
Reporting Period:
2014-04-03
Filing Date:
2014-06-03
Accepted Time:
2014-06-03 21:28:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266275 Kate Mitchell 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
1308328 Bavp, L.p. 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
1308343 Scale Venture Management I, Llc 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
1366969 Rory O'driscoll 950 Tower Lane, Suite 700
Foster City CA 94404
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-04-03 14,500 $7.47 4,848,594 No 4 S Direct
Common Stock Disposition 2014-04-04 10,969 $7.22 4,837,625 No 4 S Direct
Common Stock Disposition 2014-04-07 26,400 $6.60 4,811,225 No 4 S Direct
Common Stock Disposition 2014-04-08 22,900 $6.48 4,788,325 No 4 S Direct
Common Stock Disposition 2014-04-09 18,400 $6.64 4,769,925 No 4 S Direct
Common Stock Disposition 2014-04-10 7,800 $6.48 4,762,125 No 4 S Direct
Common Stock Disposition 2014-04-11 23,000 $6.57 4,739,125 No 4 S Direct
Common Stock Disposition 2014-04-14 13,300 $6.29 4,725,825 No 4 S Direct
Common Stock Disposition 2014-04-15 7,000 $6.28 4,718,825 No 4 S Direct
Common Stock Disposition 2014-04-16 10,900 $6.27 4,707,925 No 4 S Direct
Common Stock Disposition 2014-04-17 13,700 $6.30 4,694,225 No 4 S Direct
Common Stock Disposition 2014-04-21 9,500 $6.26 4,684,725 No 4 S Direct
Common Stock Disposition 2014-04-22 17,700 $6.27 4,667,025 No 4 S Direct
Common Stock Disposition 2014-04-24 300 $6.25 4,666,725 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 trading plan.
  2. The shares were sold at prices ranging from $7.41 to $7.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares are held by BAVP, LP ("BAVP"). The General Partner of BAVP is Scale Venture Management I, LLC ("Scale"). Kate Mitchell and Rory O'Driscoll are the managing members of Scale and share voting and investment power with respect to these shares. Each of the managing members of Scale disclaims beneficial ownership with respect to these shares except to the extent of their pecuniary interest therein.
  4. The shares were sold at prices ranging from $7.08 to $7.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The shares were sold at prices ranging from $6.43 to $6.92. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. The shares were sold at prices ranging from $6.35 to $6.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. The shares were sold at prices ranging from $6.41 to $6.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  8. The shares were sold at prices ranging from $6.42 to $6.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  9. The shares were sold at prices ranging from $6.25 to $6.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  10. The shares were sold at prices ranging from $6.25 to $6.49. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  11. The shares were sold at prices ranging from $6.25 to $6.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  12. The shares were sold at prices ranging from $6.25 to $6.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  13. The shares were sold at prices ranging from $6.25 to $6.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  14. The shares were sold at prices ranging from $6.25 to $6.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  15. The shares were sold at prices ranging from $6.25 to $6.39. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.